Original Research

Five-day regimen of intramuscular or subcutaneous self-administered adrenocorticotropic hormone gel for acute exacerbations of multiple sclerosis: a prospective, randomized, open-label pilot trial

Simsarian JP, Saunders C, Smith DM

Drug Design, Development and Therapy 2011, 5:381-389

Published Date: 11 July 2011